]>
IRCT20110306005981N3 IRCT 2018-12-25 Mashhad University of Medical Sciences Treatment of transurethral resection of the prostate. A clinical trial to compare the outcomes of transurethral resection of the prostate (TURP) and TURP plus Botox injection in patients with benign prostatic hyperplasia (BPH). 2019-01-21 anticipated 50 Complete https://irct.ir/trial/36034 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Fifty BPH patients at the Imam Reza Hospital, Mashhad, Iran, were chosen. The participants were allocated into two groups of intervention using the table of random numbers based on computer programs, Blinding description: BPH patients at Imam Reza Hospital, Mashhad, Iran, were chosen. In this double-blind study, the clinical care provider and data collector were blind to group assignment and the type of treatment. 2 Prostatic hyperplasia. Intervention 1: Intervention group: The intervention group I will receive of transurethral resection of the prostate treatment. Intervention 2: Intervention group: The intervention group II will receive of transurethral resection of the prostate with 300 U intravenous Botox at 30 different locations. Yes - There is a plan to make this available What will be shared: The total data to be included are the primary and secondary effects to be shared. When: 6 months after printing results To whom: Our data will only be available to researchers working in science center and university. Conditions: Our data will be available for scholars working in science center and university. Where to obtain: Majid Chogani provides the analysis code to the applicants via email: majidchokani@yahoo.com How to obtain: Data collection was done for 10 months, data were collected one month, statistical analysis of one month, information dissemination as a article six months. Comments:
public Maliheh Keshvari Shirvan
Imam Reza Hospital, Imam Reza Square
Mashhad Iran (Islamic Republic of) 9137913316 +98 51 1761 5063 keshvarim@mums.ac.ir Mashhad University of Medical Sciences scientific Majid Chogani
Imam Reza Hospital, Imam Reza Square
Mashhad Iran (Islamic Republic of) 9137913316 +98 51 1761 5063 majidchokani@yahoo.com Mashhad University of Medical Sciences Iran (Islamic Republic of) Age range of 50-80 years Lower urinary tract symptoms resistant to standard medical treatment international prostate symptom score (IPSS) of >12 prostate volume of >50 cm3 in ultrasound 50 years 80 years Male History of prostate surgery Having prostate cancer Having bleeding disorders Incidence of acute urinary retention during the treatment N40 Hyperplasia of prostate Treatment - Surgery Treatment - Surgery Intervention group: The intervention group I will receive of transurethral resection of the prostate treatment. Intervention group: The intervention group II will receive of transurethral resection of the prostate with 300 U intravenous Botox at 30 different locations. Clinical symptoms (e.g., dysuria, urinary frequency, and pelvic pain). Timepoint: 3, 6, and 12 months after the intervention. Method of measurement: The international prognostic scoring system (IPSS). Mashhad University of Medical Sciences Approved 2018-11-22 Ethics Committee of Mashhad University of Medical Sciences Vice Chancellor for Research, Mashhad University of Medical Sciences, Ghoreishi building, Daneshgah Street Mashhad Razavi Khorasan Iran (Islamic Republic of)